Zhou, Zien
Jardine, Meg
Perkovic, Vlado
Matthews, David R.
Mahaffey, Kenneth W.
de Zeeuw, Dick
Fulcher, Greg
Desai, Mehul
Oh, Richard
Simpson, Roger
Watts, Nelson B.
Neal, Bruce
Funding for this research was provided by:
Janssen Research & Development, LLC
Article History
Received: 10 April 2019
Accepted: 7 June 2019
First Online: 10 August 2019
Duality of interest
: ZZ reports receiving a Scientia PhD Scholarship from the University of New South Wales, Sydney. MJ is supported by a Medical Research Future Fund Next Generation Clinical Researchers Program Career Development Fellowship; is responsible for research projects that have received unrestricted funding from Gambro, Baxter, CSL, Amgen, Eli Lilly and Merck; has served on advisory boards sponsored by Akebia, Baxter and Boehringer Ingelheim; and has spoken at scientific meetings sponsored by Janssen, Amgen and Roche, with any consultancy, honoraria or travel support paid to her institution. VP reports receiving research support from the Australian National Health and Medical Research Council (Senior Research Fellowship and Program Grant); serving on Steering Committees for AbbVie, Boehringer Ingelheim, GlaxoSmithKline, Janssen and Pfizer; and serving on advisory boards and/or speaking at scientific meetings for AbbVie, Astellas, AstraZeneca, Bayer, Baxter, Bristol-Myers Squibb, Boehringer Ingelheim, Durect, Eli Lilly, Gilead, GlaxoSmithKline, Janssen, Merck, Novartis, Novo Nordisk, Pfizer, Pharmalink, Relypsa, Roche, Sanofi, Servier and Vitae with all honoraria paid to his employer. DRM reports receiving research support from Janssen; serving on advisory boards and as a consultant for Novo Nordisk, Novartis, Sanofi-Aventis, Janssen and Servier; and giving lectures for Novo Nordisk, Servier, Sanofi-Aventis, Novartis, Janssen, Mitsubishi Tanabe and Aché Laboratories. KWM’s disclosures can be viewed at ExternalRef removed. DdZ reports serving on advisory boards and/or as a speaker for Bayer, Boehringer Ingelheim, Fresenius, Mundipharma, Mitsubishi Tanabe; serving on steering committees and/or as a speaker for AbbVie and Janssen; and on data safety and monitoring committees for Bayer. GF reports receiving research support from Novo Nordisk and serving on advisory boards and as a consultant for Janssen, Novo Nordisk, Boehringer Ingelheim and Merck Sharp & Dohme. MD, RO and RS report being full-time employee of Janssen Research & Development, LLC. NBW reports serving as a consultant to Janssen. BN reports receiving research support from the Australian National Health and Medical Research Council Principal Research Fellowship and from Janssen, Roche, Servier and Merck Schering Plough; and serving on advisory boards and/or involvement in continuing medical education programmes for Abbott, Janssen, Novartis, Pfizer, Roche and Servier with any consultancy, honoraria or travel support paid to his institution.